Loading news...
Intuitive Surgical's growth rate was around 19% last quarter. The company has been growing steadily over the years, and it still has plenty of potential in the long term.
ProShare Advisors LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 18.3% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 454,524 shares of the medical equipment provider's stock after selling 102,046 shares during the
Oppenheimer Asset Management Inc. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 3.1% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 54,958 shares of the medical equipment provider's stock after acquiring an additional 1,650
Intuitive Surgical is the world's No. 1 robotic surgery company.
Alphinity Investment Management Pty Ltd reduced its holdings in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 12.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 770,716 shares of the medical equipment provider's stock after selling 108,992 shares during the period. Intuitive Surgical accounts
Intuitive Surgical's recent dip is a good buying opportunity, considering its prospects. Vertex Pharmaceuticals' shares could jump this year as it advances its clinical programs.
Intuitive Surgical makes the da Vinci surgical robot. The company is growing strongly but has a lofty price tag.
Waterloo Capital L.P. lowered its position in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 21.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,008 shares of the medical equipment provider's stock after selling 1,103 shares during the quarter. Waterloo Capital L.P.'s
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Envestnet Asset Management Inc. decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 3.9% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 518,719 shares of the medical equipment provider's stock after selling 21,105 shares
Intuitive Surgical, Inc. (NASDAQ: ISRG - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the twenty-six brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating, fifteen have given a buy rating and two have given
ISRG posts 20.5% revenue growth in 2025, driven by higher procedure volumes and da Vinci 5 adoption, and guides for 13-15% procedure growth in 2026.
Bessemer Group Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 22.8% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 967,778 shares of the medical equipment provider's stock after purchasing an additional 179,450 shares during the quarter. Bessemer
HighPoint Advisor Group LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 112.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,205 shares of the medical equipment provider's stock after buying an additional 8,052 shares during the period.
Intuitive Surgical remains a compelling long-term buy despite recent share price weakness and mixed Q4 results. Da Vinci 5 adoption is robust, with 74% YoY system placement growth and expanding FDA-approved use cases. 2026 guidance is soft, with procedure growth expected to slow to 13–15%, but headwinds are seen as temporary.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Strategy Asset Managers LLC trimmed its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 23.3% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,460 shares of the medical equipment provider's stock after selling 1,051 shares during the period. Strategy
Intuitive Surgical, Inc. (NASDAQ: ISRG - Get Free Report) EVP Myriam Curet sold 126 shares of the company's stock in a transaction dated Thursday, January 29th. The shares were sold at an average price of $520.02, for a total transaction of $65,522.52. The transaction was disclosed in a filing with the Securities and Exchange Commission, which
Foundations Investment Advisors LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 93.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,715 shares of the medical equipment provider's stock after selling 37,895 shares during
Intuitive Surgical is an industry leader in surgical robotics. The company continues to sell many da Vinci systems, which power its parts and services revenue.